Pharm Block IV Flashcards
Sermorelin
GHRH
Mecasermin
IGF-1
abnormal GH receptor
AE: hypoglycemia
Somatropin/Somatrein
GH
AE: leukemia, HypoThyroid, Insulin resistance, Arthralgia, CYP450
Octreotide
somatostatin analog
STOP GH secretion
TX: acromegaly, carcinoid crisis, VIPoma, GI bleeding
AE: GI, heart, HYPOglycemia, gallstones
PeGvisomANT
GH receptor ANTagonist (no dimerization) DEC IGF-1 TX: acromegaly long t1/2 AE: INC GH secretion (INC pit adenoma size), INC aminotransferanse (MRI, Liver Labs)
MenoTROPINS
HCG
UrofolliTROPIN
FolliTROPIN
TROPINs (except soma)
FSH/LH
TX: IVF, anovulation
AE: ovarian cyst, gynecomastia
GnRH
Gonadorelin
GnRH agonist PULSATILE
TX: hypogonadism, infertility
GoseRELIN HisteRELIN LeuproLIDE NafaRELIN TriptoRELIN
RELINs + LIDE (not gonaderlin)
GnRH agonist SUSTAINED
(BIPHASIC: agonist first, inhibitory long term)
TX: endometriosis, breast and ovarian cancer, amenorrhea in PCOS
AE: menopause sx, osteoporosis, urogenital
CI: pregnancy, breast feeding
GaniRELIX
CetroRELIX
AbaRELIX
RELIXs GnRH receptor Antagonist Inhibit FSH/LH in dose dependent TX: IVF aba x metastatic prostate cancer AE: QT prolong CI: ovarian failure, thyroid, adrenal dysfunction
Bromocriptine (cycloset)
CarberGOLIne
PerGOLIde
QuinaGOLIder
GOLIs + Bromo
Dopamine receptor agonist (Inhibit prolactin release)
TX: hyperprolactinemia, Parkinson’s
AE: orthostatic HTN, seizure, heart and lung ae
NAUSEA: C
Conjugated estrogens
Estradiol (transdermal)
Ethanol Estradiol
Diethylstilbestrol (DES)
estrogens “synthetic”
TX: menopause, osteoporosis, vaginal atrophy
AE: Adenocarcinoma in DES daughters
Tamoxifen
SERM (ER ANTAgonist at breast; AGOnist at endometrium, bone)
TX: Breast Cancer (prevention, palliative and adjuvant) - pre and post menopause
AE: Cancer endometrium, cataract, PE
CI: DVT/PE, pregnancy
Clomiphene
SERM (ER ANTAgonist in pit, hypothalamus, ovaries)
–> GnRH release (FSH/LH)
TX: infertility (ovulatory dz)
AE: emboli
CI: pregnancy, thyroid/adrenal insufficiency, liver dz, endometrial carcinoma
Raloxifene
SERM (ER ANTAgonist uterus, breast’ AGOnist bone)
TX: osteoporosis, *DEC risk of invasive breast cancer in postmenopausal
AE: vascular occlusion, emboli
CI: pregnancy, emboli
FulvESTrANT
Inhibit ER receptors (ANTAGONIST only)
TX: breast cancer ER+ in postmenopausal with dx after anti-estrogen therapy
AE: asthenia (no strength)
CI: pregnancy
AnastrOZOLE
LetrOZOLE
OZOLEs
Inhibit Aromatase - competitive (NO androgen->estrogen)
TX: breast cancer ER+
AE: osteoporotic fractures
ExeMESTANE
ForMESTANE
Inhibit Aromatase - Irreversible
NOrGESTrel
NOrethindrone
Methoxyprogesterone acetate
EtoNOGESTrel
LevoNOrGESTrel
alter GnRH frequency/pulsing (contraception - progestin only)
Levo - emergency “morning after pill”
AE: irregular spotting/bleed
CI: acute liver dz/cancer, breast cancer, pregnancy
MifePRISTOne
Inhibit Progesterone receptor (normal dose)
TX: ABORTION
Inhibit glucocorticoid receptor (high dose) - DEC cortisol response
AE: sepsis
Ethylene-estradiol + Norgestrel
Ethinylestradiol + Drospienne
alter GnRH frequency/pulsing –> NO ovulation
(contraception - Estrogen + Progesterone)
AE: ER+ cancer, smokers
Testosteron Enanthate
Testosteron Cypionate
Testosteron (HRT) –> androgenic effects
TX: hypogonadism
Transdermal (no first metabolism)
Flutamide
Inhibit DHT/Testosteron receptor
(Androgen Receptor Antagonist)
TX: metastatic prostate cancer, BPH
Spironolactone
Inhibit DHT/Testosteron receptor
(Androgen Receptor Antagonist)
Aldosterone receptor antagonist
AE: hirsutism, HTN, acne, edema, kidney dz, HypoKalemia
CI: acute RF, Hyperkalemia
FINEstaride
FINE = FIVE Inhibit type II 5alpha-reductase (NO testosteron->DHT) TX: BPH, androgenic alopecia CI: pregnancy, women Alternative to TRUP